List of Tables
Table 1. Inflammatory Bowel Disease Drugs Market Trends
Table 2. Inflammatory Bowel Disease Drugs Market Drivers & Opportunity
Table 3. Inflammatory Bowel Disease Drugs Market Challenges
Table 4. Inflammatory Bowel Disease Drugs Market Restraints
Table 5. Global Inflammatory Bowel Disease Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Inflammatory Bowel Disease Drugs Revenue Market Share by Company (2019-2024)
Table 7. Global Inflammatory Bowel Disease Drugs Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Inflammatory Bowel Disease Drugs Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Inflammatory Bowel Disease Drugs Price by Company (2019-2024) & (USD/Unit)
Table 10. Key Manufacturers Inflammatory Bowel Disease Drugs Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Inflammatory Bowel Disease Drugs Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Inflammatory Bowel Disease Drugs
Table 13. Global Inflammatory Bowel Disease Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inflammatory Bowel Disease Drugs as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Inflammatory Bowel Disease Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Inflammatory Bowel Disease Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Inflammatory Bowel Disease Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Inflammatory Bowel Disease Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Inflammatory Bowel Disease Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Inflammatory Bowel Disease Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Inflammatory Bowel Disease Drugs Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Inflammatory Bowel Disease Drugs Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Inflammatory Bowel Disease Drugs Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Inflammatory Bowel Disease Drugs Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Inflammatory Bowel Disease Drugs Price by Type (2019-2024) & (USD/Unit)
Table 27. Global Inflammatory Bowel Disease Drugs Price by Type (2025-2030) & (USD/Unit)
Table 28. Global Inflammatory Bowel Disease Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Inflammatory Bowel Disease Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Inflammatory Bowel Disease Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Inflammatory Bowel Disease Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Inflammatory Bowel Disease Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Inflammatory Bowel Disease Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Inflammatory Bowel Disease Drugs Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Inflammatory Bowel Disease Drugs Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Inflammatory Bowel Disease Drugs Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Inflammatory Bowel Disease Drugs Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Inflammatory Bowel Disease Drugs Price by Application (2019-2024) & (USD/Unit)
Table 39. Global Inflammatory Bowel Disease Drugs Price by Application (2025-2030) & (USD/Unit)
Table 40. Global Inflammatory Bowel Disease Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Inflammatory Bowel Disease Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Inflammatory Bowel Disease Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Inflammatory Bowel Disease Drugs Sales Value by Region (2019-2024) & (%)
Table 44. Global Inflammatory Bowel Disease Drugs Sales Value by Region (2025-2030) & (%)
Table 45. Global Inflammatory Bowel Disease Drugs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Inflammatory Bowel Disease Drugs Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Inflammatory Bowel Disease Drugs Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Inflammatory Bowel Disease Drugs Sales Volume by Region (2019-2024) & (%)
Table 49. Global Inflammatory Bowel Disease Drugs Sales Volume by Region (2025-2030) & (%)
Table 50. Global Inflammatory Bowel Disease Drugs Average Price by Region (2019-2024) & (USD/Unit)
Table 51. Global Inflammatory Bowel Disease Drugs Average Price by Region (2025-2030) & (USD/Unit)
Table 52. Key Countries/Regions Inflammatory Bowel Disease Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Inflammatory Bowel Disease Drugs Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Inflammatory Bowel Disease Drugs Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Inflammatory Bowel Disease Drugs Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Inflammatory Bowel Disease Drugs Sales Volume, (2025-2030) & (K Units)
Table 57. Abbott Laboratories Company Information
Table 58. Abbott Laboratories Introduction and Business Overview
Table 59. Abbott Laboratories Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Abbott Laboratories Inflammatory Bowel Disease Drugs Product Offerings
Table 61. Abbott Laboratories Recent Development
Table 62. Biocon Ltd Company Information
Table 63. Biocon Ltd Introduction and Business Overview
Table 64. Biocon Ltd Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 65. Biocon Ltd Inflammatory Bowel Disease Drugs Product Offerings
Table 66. Biocon Ltd Recent Development
Table 67. Roche Company Information
Table 68. Roche Introduction and Business Overview
Table 69. Roche Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 70. Roche Inflammatory Bowel Disease Drugs Product Offerings
Table 71. Roche Recent Development
Table 72. Johnson and Johnson Company Information
Table 73. Johnson and Johnson Introduction and Business Overview
Table 74. Johnson and Johnson Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 75. Johnson and Johnson Inflammatory Bowel Disease Drugs Product Offerings
Table 76. Johnson and Johnson Recent Development
Table 77. Mylan Pharmaceuticals Company Information
Table 78. Mylan Pharmaceuticals Introduction and Business Overview
Table 79. Mylan Pharmaceuticals Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 80. Mylan Pharmaceuticals Inflammatory Bowel Disease Drugs Product Offerings
Table 81. Mylan Pharmaceuticals Recent Development
Table 82. Novartis AG Company Information
Table 83. Novartis AG Introduction and Business Overview
Table 84. Novartis AG Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 85. Novartis AG Inflammatory Bowel Disease Drugs Product Offerings
Table 86. Novartis AG Recent Development
Table 87. Pfizer Company Information
Table 88. Pfizer Introduction and Business Overview
Table 89. Pfizer Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 90. Pfizer Inflammatory Bowel Disease Drugs Product Offerings
Table 91. Pfizer Recent Development
Table 92. Quest Medical Company Information
Table 93. Quest Medical Introduction and Business Overview
Table 94. Quest Medical Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 95. Quest Medical Inflammatory Bowel Disease Drugs Product Offerings
Table 96. Quest Medical Recent Development
Table 97. Sanofi Company Information
Table 98. Sanofi Introduction and Business Overview
Table 99. Sanofi Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 100. Sanofi Inflammatory Bowel Disease Drugs Product Offerings
Table 101. Sanofi Recent Development
Table 102. Takeda Pharmaceutical Company Information
Table 103. Takeda Pharmaceutical Introduction and Business Overview
Table 104. Takeda Pharmaceutical Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 105. Takeda Pharmaceutical Inflammatory Bowel Disease Drugs Product Offerings
Table 106. Takeda Pharmaceutical Recent Development
Table 107. AbbVie Inc Company Information
Table 108. AbbVie Inc Introduction and Business Overview
Table 109. AbbVie Inc Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 110. AbbVie Inc Inflammatory Bowel Disease Drugs Product Offerings
Table 111. AbbVie Inc Recent Development
Table 112. Bristol Myers Squibb Company Information
Table 113. Bristol Myers Squibb Introduction and Business Overview
Table 114. Bristol Myers Squibb Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 115. Bristol Myers Squibb Inflammatory Bowel Disease Drugs Product Offerings
Table 116. Bristol Myers Squibb Recent Development
Table 117. Celltrion Healthcare Company Information
Table 118. Celltrion Healthcare Introduction and Business Overview
Table 119. Celltrion Healthcare Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 120. Celltrion Healthcare Inflammatory Bowel Disease Drugs Product Offerings
Table 121. Celltrion Healthcare Recent Development
Table 122. Eli-Lilly Company Information
Table 123. Eli-Lilly Introduction and Business Overview
Table 124. Eli-Lilly Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 125. Eli-Lilly Inflammatory Bowel Disease Drugs Product Offerings
Table 126. Eli-Lilly Recent Development
Table 127. Merck & Co, Inc Company Information
Table 128. Merck & Co, Inc Introduction and Business Overview
Table 129. Merck & Co, Inc Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 130. Merck & Co, Inc Inflammatory Bowel Disease Drugs Product Offerings
Table 131. Merck & Co, Inc Recent Development
Table 132. UCB S.A. Company Information
Table 133. UCB S.A. Introduction and Business Overview
Table 134. UCB S.A. Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 135. UCB S.A. Inflammatory Bowel Disease Drugs Product Offerings
Table 136. UCB S.A. Recent Development
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Inflammatory Bowel Disease Drugs Downstream Customers
Table 140. Inflammatory Bowel Disease Drugs Distributors List
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Inflammatory Bowel Disease Drugs Product Picture
Figure 2. Global Inflammatory Bowel Disease Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Inflammatory Bowel Disease Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Inflammatory Bowel Disease Drugs Sales Volume (2019-2030) & (K Units)
Figure 5. Global Inflammatory Bowel Disease Drugs Sales Price (2019-2030) & (USD/Unit)
Figure 6. Inflammatory Bowel Disease Drugs Report Years Considered
Figure 7. Global Inflammatory Bowel Disease Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Inflammatory Bowel Disease Drugs Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Inflammatory Bowel Disease Drugs Revenue in 2023
Figure 10. Inflammatory Bowel Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Amino-salicylates Picture
Figure 12. Antibiotics Picture
Figure 13. Corticosteroids Picture
Figure 14. Immunomodulators Picture
Figure 15. Biologics Picture
Figure 16. Others Picture
Figure 17. Global Inflammatory Bowel Disease Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Inflammatory Bowel Disease Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 19. Global Inflammatory Bowel Disease Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 20. Global Inflammatory Bowel Disease Drugs Sales Volume Market Share by Type, 2023 & 2030
Figure 21. Global Inflammatory Bowel Disease Drugs Price by Type (2019-2030) & (USD/Unit)
Figure 22. Product Picture of Ulcerative Colitis
Figure 23. Product Picture of Crohns Disease
Figure 24. Product Picture of Indeterminate Colitis
Figure 25. Product Picture of Others
Figure 26. Global Inflammatory Bowel Disease Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 27. Global Inflammatory Bowel Disease Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 28. Global Inflammatory Bowel Disease Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 29. Global Inflammatory Bowel Disease Drugs Sales Volume Market Share by Application, 2023 & 2030
Figure 30. Global Inflammatory Bowel Disease Drugs Price by Application (2019-2030) & (USD/Unit)
Figure 31. North America Inflammatory Bowel Disease Drugs Sales Value (2019-2030) & (US$ Million)
Figure 32. North America Inflammatory Bowel Disease Drugs Sales Value by Country (%), 2023 VS 2030
Figure 33. Europe Inflammatory Bowel Disease Drugs Sales Value (2019-2030) & (US$ Million)
Figure 34. Europe Inflammatory Bowel Disease Drugs Sales Value by Country (%), 2023 VS 2030
Figure 35. Asia Pacific Inflammatory Bowel Disease Drugs Sales Value (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Inflammatory Bowel Disease Drugs Sales Value by Country (%), 2023 VS 2030
Figure 37. South America Inflammatory Bowel Disease Drugs Sales Value (2019-2030) & (US$ Million)
Figure 38. South America Inflammatory Bowel Disease Drugs Sales Value by Country (%), 2023 VS 2030
Figure 39. Middle East & Africa Inflammatory Bowel Disease Drugs Sales Value (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Inflammatory Bowel Disease Drugs Sales Value by Country (%), 2023 VS 2030
Figure 41. Key Countries/Regions Inflammatory Bowel Disease Drugs Sales Value (%), (2019-2030)
Figure 42. Key Countries/Regions Inflammatory Bowel Disease Drugs Sales Volume (%), (2019-2030)
Figure 43. United States Inflammatory Bowel Disease Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 44. United States Inflammatory Bowel Disease Drugs Sales Value by Type (%), 2023 VS 2030
Figure 45. United States Inflammatory Bowel Disease Drugs Sales Value by Application (%), 2023 VS 2030
Figure 46. Europe Inflammatory Bowel Disease Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 47. Europe Inflammatory Bowel Disease Drugs Sales Value by Type (%), 2023 VS 2030
Figure 48. Europe Inflammatory Bowel Disease Drugs Sales Value by Application (%), 2023 VS 2030
Figure 49. China Inflammatory Bowel Disease Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 50. China Inflammatory Bowel Disease Drugs Sales Value by Type (%), 2023 VS 2030
Figure 51. China Inflammatory Bowel Disease Drugs Sales Value by Application (%), 2023 VS 2030
Figure 52. Japan Inflammatory Bowel Disease Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 53. Japan Inflammatory Bowel Disease Drugs Sales Value by Type (%), 2023 VS 2030
Figure 54. Japan Inflammatory Bowel Disease Drugs Sales Value by Application (%), 2023 VS 2030
Figure 55. South Korea Inflammatory Bowel Disease Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 56. South Korea Inflammatory Bowel Disease Drugs Sales Value by Type (%), 2023 VS 2030
Figure 57. South Korea Inflammatory Bowel Disease Drugs Sales Value by Application (%), 2023 VS 2030
Figure 58. Southeast Asia Inflammatory Bowel Disease Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 59. Southeast Asia Inflammatory Bowel Disease Drugs Sales Value by Type (%), 2023 VS 2030
Figure 60. Southeast Asia Inflammatory Bowel Disease Drugs Sales Value by Application (%), 2023 VS 2030
Figure 61. India Inflammatory Bowel Disease Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 62. India Inflammatory Bowel Disease Drugs Sales Value by Type (%), 2023 VS 2030
Figure 63. India Inflammatory Bowel Disease Drugs Sales Value by Application (%), 2023 VS 2030
Figure 64. Inflammatory Bowel Disease Drugs Industrial Chain
Figure 65. Inflammatory Bowel Disease Drugs Manufacturing Cost Structure
Figure 66. Channels of Distribution (Direct Sales, and Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
